Abbott Laboratories
USD87.02
+0.05 (+0.06%)
CEO
Robert Ford
IPO Date
1980-03-17
Sector
Healthcare
Industry
Medical - Devices
Exchange
NYSE
Country
US
Open
$87.19
Prev. Close
$86.97
Day Low
$86.72
Day High
$88.11
52W Low
$81.97
52W High
$139.06
Market Cap
$151.57B
Volume
10.38M
| 14.6 |
| 31 Dec 2023 | FY | 55.2% | 14.3% | 14.8% | 7.8% | 0.41 | 1.64 | 33.4 |
| 31 Dec 2022 | FY | 56.1% | 15.9% | 18.9% | 9.3% | 0.48 | 1.63 | 27.8 |
| 31 Dec 2021 | FY | 57.0% | 16.4% | 19.8% | 9.4% | 0.53 | 1.85 | 35.1 |
| 31 Dec 2020 | FY | 56.6% | 13.0% | 13.7% | 6.2% | 0.60 | 1.72 | 43.1 |
| 31 Dec 2019 | FY | 58.5% | 11.6% | 11.9% | 5.4% | 0.61 | 1.44 | 41.5 |
| 31 Dec 2018 | FY | 58.4% | 7.7% | 7.8% | 3.5% | 0.64 | 1.62 | 53.6 |
| 31 Dec 2017 | FY | 55.0% | 1.7% | 1.5% | 0.6% | 0.90 | 2.26 | 208.6 |
| 31 Dec 2016 | FY | 56.7% | 6.7% | 6.8% | 2.7% | 1.07 | 4.02 | 40.4 |
| 35.6 |
| 30 Jun 2025 | Q2 | 56.4% | 16.0% | 3.5% | 2.1% | 0.27 | 1.82 | 33.3 |
| 31 Mar 2025 | Q1 | 52.6% | 12.8% | 2.7% | 1.6% | 0.27 | 1.78 | 43.7 |
| 31 Dec 2024 | Q4 | 55.0% | 84.1% | 19.4% | 11.3% | 0.32 | 1.67 | 5.3 |
| 30 Sept 2024 | Q3 | 55.8% | 15.5% | 4.1% | 2.2% | 0.38 | 1.60 | 30.0 |
| 30 Jun 2024 | Q2 | 56.0% | 12.5% | 3.3% | 1.8% | 0.38 | 1.68 | 34.4 |
| 31 Mar 2024 | Q1 | 55.6% | 12.3% | 3.2% | 1.7% | 0.38 | 1.60 | 39.7 |
| 31 Dec 2023 | Q4 | 51.3% | 15.6% | 4.1% | 2.2% | 0.39 | 1.64 | 29.9 |
| 30 Sept 2023 | Q3 | 54.6% | 14.2% | 3.8% | 2.0% | 0.41 | 1.74 | 29.3 |